Global Diagnostics Partnering Terms and Agreements 2015-2022

$3,495.00

The Global Diagnostics Partnering Terms and Agreements 2015-2022 report provides comprehensive understanding and unprecedented access to the diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies.

Publication date
May 2022
Number of pages
1,600+
Product type
Research report
Available formats
PDF document
Report edition
3
SKU
CP2104

The Global Diagnostics Partnering Terms and Agreements 2015-2022 report provides comprehensive understanding and unprecedented access to the diagnostic partnering agreements entered into by the worlds leading companies.

  • Comprehensive directory of diagnostic deals since 2015
  • Diagnostic contract documents
  • Diagnostic agreement terms
  • Diagnostic agreement structure
  • Top diagnostic deals by value
  • Most active diagnostic dealmakers

 

This report provides details of the latest diagnostics agreements announced in the healthcare sectors, covering: 

  • Companion Diagnostics
  • Imaging
  • CT
  • Endoscope
  • Molecular and nuclear
  • MRI
  • Ultrasound
  • X-ray
  • PET
  • SPECT
  • Angiography
  • Fluroscopy
  • Mammography
  • In vitro diagnostics
  • Molecular diagnostics
  • Prognostics
  • Theranostics

 

The report provides a detailed understanding and analysis of how and why companies enter Diagnostics partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and proceed to commercialization of outcomes.

This report provides details of the latest Diagnostics agreements announced in the life sciences since 2015.

The report takes the reader through a comprehensive review Diagnostics deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Diagnostics partnering deals.

The report presents financial deal term values for Diagnostics deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.

The middle section of the report explores the leading dealmakers in the Diagnostics partnering field; both the leading deal values and most active Diagnostics dealmaker companies are reported allowing the reader to see who is succeeding in this dynamic dealmaking market.

One of the key highlights of the report is that over 3,000 online deal records of actual Diagnostics deals, as disclosed by the deal parties, are included towards the end of the report in a directory format – by company A-Z, stage of development, deal type, therapy focus, and technology type - that is easy to reference. Each deal record in the report links via Weblink to an online version of the deal.

In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners. Whilst many companies will be seeking details of the payment clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not.

The initial chapters of this report provide an orientation of Diagnostics dealmaking. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in Diagnostics dealmaking since 2015, including details of headline, upfront, milestone and royalty terms.

Chapter 3 provides a review of the leading Diagnostics deals since 2015. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 4 provides a comprehensive listing of the top 25 most active companies in Diagnostics dealmaking with a brief summary followed by a comprehensive listing of Diagnostics deals announded by that company, as well as contract documents, where available.

Chapter 5 provides a comprehensive and detailed review of Diagnostics partnering deals signed and announced since Jan 2015, where a contract document is available in the public domain. Each deal title links via Weblink to an online version of the deal record and contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive and detailed review of Diagnostics partnering deals signed and announced since Jan 2015. The chapter is organized by specific Diagnostics technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.

A comprehensive series of appendices is provided organized by Diagnostics partnering company A-Z, stage of development, deal type, and therapy focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in Diagnostics partnering and dealmaking since 2015.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Diagnostics technologies and products.

 

Key benefits

Global Diagnostics Partnering Terms and Agreements 2015-2022 provides the reader with the following key benefits:

 

  • In-depth understanding of Diagnostics deal trends since 2015
  • Access to headline, upfront, milestone and royalty data
  • Detailed access to actual Diagnostics contracts entered into by leading biopharma companies
  • Identify most active Diagnostics dealmakers since 2015
  • Insight into terms included in a Diagnostics partnering agreement, with real world examples
  • Understand the key deal terms companies have agreed in previous deals           
  • Undertake due diligence to assess suitability of your proposed deal terms for partner companies

 

Report scope

Global Diagnostics Partnering Terms and Agreements 2015-2022 is intended to provide the reader with an in-depth understanding and access to Diagnostics trends and structure of deals entered into by leading companies worldwide.

Diagnostics Partnering Terms and Agreements includes:

 

  • Trends in Diagnostics dealmaking in the biopharma industry since 2015
  • Access to headline, upfront, milestone and royalty data
  • Access to Diagnostics contract documents
  • Leading Diagnostics deals by value since 2015
  • Most active Diagnostics dealmakers since 2015

 

In Global Diagnostics Partnering Terms and Agreements 2015-2022, the available deals are listed by:

  • Company A-Z
  • Headline value
  • Stage of development at signing
  • Deal component type
  • Specific therapy target
  • Technology type

 

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The Global Diagnostics Partnering Terms and Agreements 2015-2022 report provides comprehensive access to available deals and contract documents for over 3,000 Diagnostics deals.

Analyzing actual contract agreements allows assessment of the following:

  • What are the precise rights granted or optioned?
  • What is actually granted by the agreement to the partner company?
  • What exclusivity is granted?
  • What is the payment structure for the deal?
  • How are sales and payments audited?
  • What is the deal term?
  • How are the key terms of the agreement defined?
  • How are IPRs handled and owned?
  • Who is responsible for commercialization?
  • Who is responsible for development, supply, and manufacture?
  • How is confidentiality and publication managed?
  • How are disputes to be resolved?
  • Under what conditions can the deal be terminated?
  • What happens when there is a change of ownership?
  • What sublicensing and subcontracting provisions have been agreed?
  • Which boilerplate clauses does the company insist upon?
  • Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
  • Which jurisdiction does the company insist upon for agreement law?

Global Diagnostics Partnering Terms and Agreements 2015-2022 provides the reader with the following key benefits:

 

  • In-depth understanding of Diagnostics deal trends since 2015
  • Access to headline, upfront, milestone and royalty data
  • Detailed access to actual Diagnostics contracts entered into by leading biopharma companies
  • Identify most active Diagnostics dealmakers since 2015
  • Insight into terms included in a Diagnostics partnering agreement, with real world examples
  • Understand the key deal terms companies have agreed in previous deals           
  • Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Executive Summary

 

Chapter 1 – Introduction

 

Chapter 2 – Trends in Diagnostics dealmaking

 

2.1. Introduction

2.2. Diagnostics partnering over the years

2.3. Most active Diagnostics dealmakers

2.4. Diagnostics partnering by deal type

2.5. Diagnostics partnering by therapy area

2.6. Deal terms for Diagnostics partnering

2.6.1 Diagnostics partnering headline values

2.6.2 Diagnostics deal upfront payments

2.6.3 Diagnostics deal milestone payments

2.6.4 Diagnostics royalty rates

 

Chapter 3 – Leading Diagnostics deals

 

3.1. Introduction

3.2. Top Diagnostics deals by value

 

Chapter 4 – Most active Diagnostics dealmakers

 

4.1. Introduction

4.2. Most active Diagnostics dealmakers

4.3. Most active Diagnostics partnering company profiles

 

Chapter 5 – Diagnostics contracts dealmaking directory

 

5.1. Introduction

5.2. Diagnostics contracts dealmaking directory

 

Chapter 6 – Diagnostics dealmaking by technology type

 

Appendices

 

Appendix 1 – Diagnostics deals by company A-Z

 

Appendix 2 – Diagnostics deals by stage of development

Discovery

Preclinical

Phase I

Phase II

Phase III

Regulatory

Marketed

Formulation

 

Appendix 3 – Diagnostics deals by deal type

 

Asset purchase

Assignment

Bigpharma outlicensing

Co-development

Collaborative R&D

Co-market

Co-promotion

CRADA

Cross-licensing

Development

Distribution

Equity purchase

Evaluation        

Grant

Joint venture

Licensing

Litigation

Manufacturing

Marketing

Material transfer

Option

Promotion

Research

Settlement

Spin out

Sub-license

Supply

Technology transfer

Termination

Warranty

 

Appendix 4 – Diagnostics deals by therapy area

Appendix 5 – Deal type definitions

Appendix 6 – Further reading on dealmaking

About Wildwood Ventures

Current Partnering

Current Agreements

Recent report titles from Current Partnering

 

Table of figures

 

Figure 1: Diagnostics partnering since 2015

Figure 2: Active Diagnostics dealmaking activity since 2015

Figure 3: Diagnostics partnering by deal type since 2015

Figure 4: Diagnostics partnering by disease type since 2015

Figure 5: Diagnostics deals with a headline value

Figure 6: Diagnostics deals with an upfront value

Figure 7: Diagnostics deals with a milestone value

Figure 8: Diagnostics deals with a royalty rate value

Figure 9: Top Diagnostics deals by value since 2015

Figure 10: Most active Diagnostics dealmakers since 2015

Pricing options

  • $3,495: single-user
  • $5,245: multi-user
  • $10,495: single site license
  • $17,495: global site license

 

A full explanation of license type definitions can be found here.

 

Our guarantee

 

Price promise

We guarantee our prices are competitive. If you find the same report advertised at a lower price within 7 days of purchase, we will refund the difference.

 

Delivery Deadline

We guarantee that the report will be sent within the specified delivery times. In the unlikely case of a delay we may offer a partial refund as compensation. (Terms may apply)

 

Latest report

If an update is published within 30 days of your purchase, you will receive it absolutely free of charge.

 

Serious Security

We take your data and security seriously. See our privacy policy for details of how we manage your data.

All card payments are processed by SagePay.

 

Sales Support

If you have any questions about your report or are unhappy with the quality, we will do our best to resolve your query. Contact us direct.

 

Total Trust

Current Partnering is part of Wildwood Ventures Ltd., based in York, United Kingdom. We have been trading successfully online since 2009 and work with some of the most famous brands in the business. We carefully select our partners to ensure that the publications meet expectations of demanding customers.

1health.io, 2bPrecise, 2cureX, 3a-diagnostics, 3B Pharmaceuticals, 3D BioMed, 3Derm Systems, 3DR Labs, 3D Signatures, 3M, 3PrimeDx, 4D Path, 5-Diagnostics, 7D Surgical, 10X Genomics, 14M Genomics, 22nd Century, 23andMe, 221b Foundation, 1717 Life Science Ventures, A*STAR Agency for Science, Technology and Research, A*STAR Institute of Microelectronics (IME), A2 Biotherapeutics, AAM Healthcare, AB Analitica, Abaxis, Abbisko Therapeutics, Abbott Laboratories, Abbott Rapid Diagnostics, Abbvie, Abcam, Abcodia, Abionic, Abramson Cancer Center, Acacia Research, Accelerate Diagnostics, Accelerate Technologies, Access BIO, Accudata Systems, AccuGenomics, Accurate Diagnostic Laboratories, Accuray, AccuRef Diagnostics, Accu Reference Medical Laboratory, Accuscience, AceCGT Life Science, Achaogen, Acibadem University, AC Immune, ACIST Medical Systems, ACON Biotech, Acon Labs, Acoustic MedSystems, Actelion, ACT Genomics, Actome, Acumen Pharmaceuticals, Acupath Laboratories, Acutus Medical, AdAlta, Adaptiiv, Adaptive Biotechnologies, Adaptive Phage Therapeutics, ADC Therapeutics, Adeptrix, Adial Pharmaceuticals, Aditx Therapeutics, ADMA Biologics, Admera Health, ADS, Advanced Accelerator Applications, Advanced Animal Diagnostics, Advanced Biological Laboratories, Advanced Cell Diagnostics, Advanced Chemistry Development, Advanced Cooling Therapy, Advanced Dermatology and Cosmetic Surgery Group, Advanced Genomic Solutions, Advanced Guidance Technologies, Advanced Human Imaging, Advanced Medical German Company of Kuwait, Advanced Nuclear Medicine Ingredients, Advanced Tear Diagnostics, Advanced Ultrasound Systems, ADx Healthcare, Aegea Biotechnologies, Aelan Cell Technologies, AEterna Zentaris, Aetna, Affymetrix, Africa Centres for Disease Control and Prevention, Africa Medical Supplies Platform, Africa Union, Agappe, Age Labs, Agena Bioscience, Agendia, Agfa HealthCare, Agilent Technologies, Agiomix FZ, Agios Pharmaceuticals, AG Mednet, AgraFlora Organics International, AID Genomics, Aidian, Aidoc, Aiforia Technologies, AIG Hospitals, AI Metrics, AIM Specialty Health, Aircraft Medical, Air Force General Hospital, Air Force Research Laboratory, AirStrip Technologies, Akers Biosciences, Ako Med, Akonni Biosystems, Akoya Biosciences, Akribis Systems, Akumin, Alab, Albany Molecular Research, Albert Einstein College of Medicine, Albert Einstein Healthcare Network, Albertsons Companies, ALBOT Technologies, Alcanna, Aldeyra Therapeutics, Alector, Alere, Aleris, Alexion Pharmaceuticals, Alfasigma, Algenex, AlgoMedica, Alibaba Health, Align Technology, AliHealth, AliveCor, ALK-Abello, Allakos, Allarity Therapeutics, Allegheny Technologies, Allele Biotechnology and Pharmaceuticals, Allergan, AllerGenis, Alliance Global FZ, Alliance Global Group, AllStripes, Alltests Clinical Solutions, Almac Diagnostics, Almac Group, Alnylam Pharmaceuticals, Alpha-Tec Systems, Alphaeon, Alphageneron Pharmaceuticals, Alpha Imaging, Alphazyme, Alpinion Medical Systems, ALR Technologies, AltaML, Altoida, Altris, Alume Biosciences, Alveo Technologies, Alverno Clinical Laboratories, Al Zahrawi Medical Supplies, Alzeca Biosciences, Alzheimer's Association, Alzheimer's Drug Discovery Foundation, Alzheimers Research UK, Alzheon, Amag Pharmaceuticals, Amarantus BioSciences, Amazon Web Services, Ambergen, Ambra Health, Ambry Genetics, Ambu, AmCad BioMed, A Menarini Diagnostics, America's Choice Provider Network, American Animal Hospital Association, American Brain Tumor Association, American College of Cardiology, American College of Chest Physicians, American Diabetes Association, American Health Imaging, American Medical Depot, American Migraine Foundation, American Oncology Network, Amerinet, Amgen, Amoy Diagnostics, Amplitech, AMRA, AMRA Medical, AMS, Amydis, Analog Devices, Analytics 4 Life, Analytics Engines, Anavasi Diagnostics, Anavex Life Sciences, AnchorDx, Andor Technology, Angany, Angle, Angsana Molecular & Diagnostics, Anixa Biosciences, Annar Health Technologies, Annoroad, Anpac Bio-Medical Science, ANP Technologies, Antaros Medical, Antech, Anteo Diagnostics, AnteoTech, Anthem, Anthem Bluecross, Antisoma Therapeutics, Apax Partners, Aperiomics, Apogenix, Apollo Med Innovations, Apple, Applied BioCode, Applied DNA Sciences, Applied Spectral Imaging, Appriss Health, APRINOIA Therapeutics, Aptagen, Aptar Pharma, Aptorum Group, Arbor Biosciences, ArcDia, ArcherDX, Arches Research, ARCHIMEDlife, Arc Medical Design, Ares Genetics, Ares Life Sciences, Areum Bio, Areva Med, Aridea Solutions, Ariosa Diagnostics, Arisan Therapeutics, Arivis, Arizona State University, Arkansas Childrens Hospital, Arkray, Arkray USA, Armed Forces Medical Research Institute, AroCell, Arquer Diagnostics, Arrow Diagnostics, Arterial Health International, Arteriomed, Arterys, Artialis, Artificial, ARTMS Product, ARUP Laboratories, Asahi Kasei, Ascendum, Ascensia Diabetes Care, Ashion Analytics, Ashvattha Therapeutics, Asieris MediTech, Aspect Imaging, Aspen Imaging Healthcare, ASPiRA Labs, Aspira Scientific, Assistance Publique-Hôpitaux de Paris, Astarte Medical, Astellas Pharma, Asterand Bioscience, Asthma UK, Astra Formedic, AstraZeneca, Astute Medical, Asuragen, AsureQuality, AtCor Medical, ATGen Global, Athinoula A Martinos Center for Biomedical Imaging, Athletigen, Atila BioSystems, Atlas Antibodies, Atlas Genetics, Atlas Genomics, Atomo Diagnostics, Atrin Pharmaceuticals, Atrys Health, Aurora Diagnostics, Aurum Ventures, Austin Health, Autism Learning Partners, Autobio Diagnostics, AutoGenomics, Avacta, Avalon GloboCare, Avant Diagnostics, AvantGen, Avantis Medical Systems, Avellino Labs, AVEO Oncology, Avera Health, Avera Heart Hospital of South Dakota, Avicenna Technology, Aviir Diagnostics, AVL Sofia, AVRA Surgical, Avricore Health, Avrobio, Avrok Laboratories, Axela, Axella Research, Axia Women's Health, Axil Scientific, AXIM Biotechnologies, Axonlab, AyoxxA Biosystems, Aytu BioPharma, AZ Sint Lucas Hospital, Babson Diagnostics, Baebies, Baker IDI Heart and Diabetes Institute, BAMF Health, Banc De Sang I Teixits, Banner Health, Banyan Biomarkers, Bardy Diagnostics, Barnabas Health, BASE10 Genetics, BASF, BATM, Battelle, Baxter International, Bay Area Lyme Foundation, Bayer, Bayer Healthcare, Bay Labs, Baylor College, Baylor College of Medicine, Baylor Genetics, BayPAT, BBI Solutions, BC Neuroimmunology, BC Platforms, BC Technical, BD Biosciences, BEAM Diagnostics, Beckman Coulter, Be Creative Lab, Becton Dickinson, BeiGene, Beijing Clear Biotech, Beijing Genomics Institute (BGI), Beijing InnoCare Pharma, Beijing Leadman Biochemistry, Beijing Podconley Pharmaceutical Technology and Development, Beijing Yuan Jian Health Management, BeMotion, Benchmark Electronics, Berg, Beroni Group, Berry Genomics, Berry Oncology, Bertech Diagnostics, Bertin Pharma, Bestbion, Bestmed, Best Supplies, Be The Match BioTherapies, Bethyl Laboratories, Better Living Now, Beurer, Beyond Batten Disease Foundation, Beyondspring Pharmaceuticals, BHR Pharma, Biim Ultrasound, Bill and Melinda Gates Foundation, BillionToOne, Binx Health, Bio-Manguinhos, Bio-Me, Bio-Rad Laboratories, Bio-Techne, bioAffinity Technologies, BioAnalytical Systems, BioArctic Neuroscience, BIOASTER, BioCanna Healthcare, Biocare Medical, Biocartis, Biocept, BioChain, BioCheck, BioClinica, Biocom Purchasing Group, BioCopy, Biodesix, Biodirection, BioDiscovery, Biodist, Biofidelity, BioFire Diagnostics, Biofourmis, BioGemex, Biogen, BIOgenetiX, BioGen Medical, Biognosys, BioGX, Biohealth Innovation, Biohit Healthcare, Bioiatriki, BioInvent, BioIQ, Biokit, Biokosmos, BioLab Sciences, Biolidics, BIOLIFE4D, Biolife Science, BioLight Life Sciences Investments, BioLizard, Biological Dynamics, BioMarin Pharmaceutical, BioMark Diagnostics, BioMarker Strategies, Biomecite Diagnostics, Biomedical Advanced Research and Development Authority, Biomedica Medizinprodukte, Biomedix, BIOMEDX Group, BioMed X Innovation Center, Biomeme, Biomerica, bioMerieux, Biomillenia, BioNano Genomics, BioNova Cientifica, BioNTech, BiopharmX, Bioportugal Quimica Farmaceutica, Bioptic, BioReference Laboratories, Bioscience Pharma Partners, Biosearch Technologies, BioSensics, BioSig Technologies, BioSkryb, BioSure, BioSymetrics, Biosynex, BioSyntagma, Biotage, Biotech-IgG, Biotechnology Innovation Organization, BioTecon Diagnostics, BioTek Instruments, BioTelemetry, BioTheranostics, bioTRADING Benelux, Biotronik, BioVaxys, Bioventix, Bioverativ, Biovica, Bioyong, Bird Foundation, BJC HealthCare, BKare Diagnostics, BL&H, Blackford, Blackfynn, Blackrock NeuroMed, BlackThorn Therapeutics, Blanchette Rockefeller Neurosciences Institute, Blinktbi, Bliss Biopharmaceutical, Blood Centers of America, Blood Systems Research Institute, Bluebee, Blue Cross Blue Shield Association, BlueCross BlueShield of Tennessee, Blue Earth Diagnostics, Bluejay Diagnostics, Blueprint Genetics, Blueprint Medicines, BluSense Diagnostics, BMV Medica, BND, Bode Technology, Boditech Med, BodyCheck, Boehringer Ingelheim, Boehringer Ingelheim Vetmedica, Bonnie J. Addario Lung Cancer Foundation, Boreal Genomics, Bosch, BostonGene, Boston IVF, Boston Medical Center, Boston Scientific, Bostwick Laboratories, Bpifrance, Bracco Diagnostics, Bracco Imaging, Brahms, Brain & Behavior Research Foundation, BRAINBox Solutions, BRAIN Initiative, BrainLAB, Brainomix, Brain Scientific, BrainScope, Brandeis University, Breakthrough Diagnostics, Breath Diagnostics, BreathTech, BriaCell Therapeutics, BrickBio, Brigham and Women's Hospital, Brigham Young University, Brik, Brio Systems, Bristol-Myers Squibb, Bristol-Myers Squibb Pakistan, Broad Institute, Brotman-Baty Institute, Brown University, Bruker, Bruker AXS, Bruker Energy & Supercon Technologies (BEST), BullFrog AI, Burkhan Group, Burning Rock, BurstIQ, Butantan Institute, Butterfly Network, BWX Technologies, C&C Irradiator Service, C2i Genomics, C2N Diagnostics, C4 Imaging, Cadila Pharmaceuticals, Calcivis, Calviri, Cambridge Blockchain, Cambridge Clinical Laboratories, Cambridge Cognition, Cambridge Consultants, Cambridge Enterprise, Cambridge Epigenetix, Cambridge Isotope Laboratories, Cambridge Research Biochemicals, Canabo Medical Clinics, Canadian Cancer Society, Canadian Institutes of Health Research, Canadian Pathology Quality Assurance, Canadian Teleradiology Services, Canary Health Technologies, CANbridge Pharmaceuticals, Cancer Australia, Cancer Genetics, Cancer Prevention and Research Institute of Texas, Cancer Research Institute, Cancer Research UK, Cancer Targeted Technology, Canon, Canon BioMedical, Canon Lifecare Solutions, Canon U.S. Life Sciences, Cantel Medical, Capital X-ray, Capnia, Caprion Proteomics, CapsoVision, Capsulomics, Caption Health, Caputron Medical, CARB-X, Cardea Bio, Cardiff University, Cardinal Health, CardiNor, CardioDx, Cardiologs, CardioNavix, Cardiowise, Cardurion Pharmaceuticals, CareDx, CareFirst BlueCross BlueShield, CareFusion, Care GB Plus, Carestream Health, Carilion Clinic, Caris Life Sciences, Carl Zeiss, Carmentix, Carolina Liquid Chemistries, Carolinas Medical Center (CMC), Carpegen, Cartana, CarThera, Case Western Reserve University, CAS Medical Systems, Castle Biosciences, Catabasis Pharmaceuticals, Catholic University Leuven, CBD Solutions, CBD Vida, CDC Foundation, CDx Diagnostics, Celcuity, Celdara Medical, Celgene, Cellex, Cellgen Diagnostics, Cell Guidance Systems, CellMax Life, Cellmic, Cellnetix, Cellpath, CellSafe, CellSight Technologies, Cell Signaling Technology, Celltrion, Celmatix, Celsee, Celsius Therapeutics, Celtic Biotech, Celularity, Cenetron, Censis Technologies, Centaur, Centene, Center for Advancing Point of Care Technologies, Center for Diagnostic Imaging (CDI), Centerline Biomedical, Centers for Disease Control and Prevention, Centogene, Centre for Addiction and Mental Health, Centre for Imaging Technology Commercialization, Centre for Probe Development and Commercialization, Centre for Structural Systems Biology, Centre Leon Berard, Cepheid, Cerba HealthCare, CerebraCell, CereHealth, Ceres, Ceres Nanosciences, Cerevast Therapeutics, CERIMED, Cernostics, Certainty Health, Cerveau Technologies, CgBio, Champalimaud Foundation, Change Healthcare, Charcot-Marie-Tooth Association, Charite Universitatsmedizin Berlin, Charles River Laboratories, CHDI Foundation, Check-Cap, CheckedUp, Chembio Diagnostics, Chemie Brunschwig, ChemImage, Chiesi Farmaceutici, Children's Hospital Boston, Children's Hospital Los Angeles, Children's Hospital of Orange County, Children's Hospital of Pittsburgh Foundation, Children's Hospital Of Wisconsin, Children's National Health System, Children’s Hospital Oakland Research Institute (CHORI), China Biotech Services, China Development Industrial Bank, China Grand Pharma, China Grand Pharmaceutical, Chindex Medical Limited, Chinese University of Hong Kong, Chinook Therapeutics, Chip-Man Technologies, Chonnam National University, Christian Doppler Research Association, Chronix Biomedical, Chronolife, Chubu University, Chugai Pharmaceutical, Chun Fo Pharmaceutical, Cicero Diagnostics, CIC Health, Cincinnati Children’s Hospital Medical Center, Cipla, CIRCA Scientific, Circle cardiovascular imaging, Circulogene, Cirle, Cirrus Dx, City of Hope, Claritas HealthTech, Clarity Pharmaceuticals, Clearbridge Biomedics, Cleared4, Clear Guide Medical, ClearLight Diagnostics, ClearPoint Neuro, Clearsky Medical Diagnostics, Cleerly, Cleveland Clinic, Cleveland Diagnostics, Cleveland HeartLab, Client Outlook, Clinatec, Clinical Enterprise, Clinical Genomics, Clinical Imaging Research Centre, Clinical Laboratory Partners, Clinical Reference Laboratory, Clinic for Special Children, Clinton Health Access Initiative, CloudHealth Genomics, Cloud Pharmaceuticals, Clovis Oncology, CLX Health, CNC Biotech, CND Life Sciences, CNS Pharmaceuticals, Co-Defend, Co-Diagnostics, CoaChrom Diagnostica, Coala Life, Coalition for Epidemic Preparedness Innovations, Cobalt Healthcare Consultants, Codexis, Coeptis Pharmaceuticals, Cofactor Genomics, Cognetivity Neurosciences, Cognoa, CogState, Cohen Veterans Bioscience, Cold Spring Harbor, Collective Medical, Colorado Melanoma Foundation, Colorado State University, Color Genomics, Columbia University, Columbia University Medical Center, Common Sense, Commonwealth Laboratories, Compact Imaging, Companion Medical, Compumedics, Conavi Medical, ConcertAI, Concert Genetics, Concile, Confirm BioSciences, Confo Therapeutics, Congenica, Consilient Health, Contextual Genomics, ContraVir Pharmaceuticals, Control Flo Medical, Cook Medical, COPAN, Copan Diagnostics, Copenhagen University Hospital, CoreBiome, Core Diagnostics India, Corgenix Medical, Coriell Life Sciences, Cornell University, Corona Diagnostics, CorTechs Labs, CorVascular, Corvida Medical, Corvium, Cosmo Bio, Cosmo Pharmaceuticals, COTA, Courtagen Life Sciences, Covance, CPR Pharma Services, CPT Medical, CQuentia, Cradle Genomics, Creoptix, CrestOptics, CR Kennedy & Company, Crohn's and Colitis Foundation of America, Crossbeta Biosciences, CrowdMed, Crown Bioscience, Crown Dental + Medical, Cruinn Diagnostics, Cryolife, CSI Laboratories, CS Medical, CStone Pharmaceuticals, Cue Health, Cumming, Curative, Curebase, Cure Brain Cancer Foundation, Cure Duchenne, Cure Forward, Cureleads, CureMetrix, Curetis, Curium, CurveBeam, Cyclenium Pharma, Cyclerion Therapeutics, Cyclopharm, Cyclotek, Cyient, CymaBay Therapeutics, Cynvenio, Cypher Genomics, Cypre, Cytiva, CytoLumina Technologies, CytoVale, Cytox, D&K Engineering, D-Eye, Dacadoo, Dahui Biotech, Daiichi Sankyo, Dako, Daktari Diagnostics, Dalrada Health, Dana-Farber Cancer Institute, Danish Center for Strategic Research into Type 2 Diabetes, DarioHealth, Dartmouth-Hitchcock Medical Center, DaRui Biotech, DarwinHealth, DASA, DATANet Software Development, Data Tecnica International, David H. Koch Institute for Integrative Cancer Research, Daxor, DCN Diagnostics, DDL Diagnostic Laboratory, Debiopharm, Decathlon Capital Partners, DeciBio Consulting, Decipher Biosciences, Deciphex, Decision Diagnostics, deCODE Genetics, Dectris, Deep Bio, Deepcell, Deep Cube, Defense Advanced Research Projects Agency, Defense Threat Reduction Agency, Definiens, Dehaier Medical Systems, Dell, Dell Medical School, Deltex Medical, Denali Therapeutics, Denator, Dendreon, Denovo Biopharma, Densitas, Denso, Dent Neurologic Institute, Department of Defense, Department of Energy, Department of Health and Human Services, Department of Public Health, Department of Veterans Affairs, DePuy, Dermpath Diagnostics, DermTech, DestiNA Genomics, Device Technologies, Devyser Diagnostics, DexCom, Diabetes Singapore, DiaCarta, Diaceutics, diaDexus, Diagen, DiagnoCure, Diagnoplex, Diagnostica Longwood, Diagnostic International Distribution, Diagnostic Oncology Contract Research Organization, DiA Imaging Analysis, DiamiR, DIAN Diagnostics, Diannei Biotechnology, Diaprost, Diasend, DiaSorin, DIAsource ImmunoAssays, Diaspective Vision, Diassess, Diasys Diagnostics Systems, Diatech Pharmacogenetics, Diaxonhit, Dicom Systems, DigiPath Solutions, Digital Diagnostics, Dilon Diagnostics, Dimerix Biosciences, Dinova Medtech, Diomics, Disior, Diversigen, DKSH, DNA Electronics, DNA Link, DNAmito, DNAnexus, DnaNudge, DNA Software, Dominion Diagnostics, Doping Control Center, Draeger Safety Diagnostics, Draper Laboratories, Drawbridge Health, DreaMed Diabetes, Dr Ho Now Health Products, Dr Risch, DuChemBio, Duchenne UK, Duke Medical, Duke University, Duke University Medical Center, Duquesne University, DxTerity, Dynasty Castle Investments, DySIS Medical, E.I. Medical Imaging, E25Bio, EarlySense, Eastern Ontario Regional Laboratory Association, Easton Pharmaceuticals, Eccrine Systems, EC Healthcare, EchelonDx, EchoNous, Echosens, Eckerd College, Eckert & Ziegler, Ecole Polytechnique Federale de Lausanne, Ecolog International, Eczacıbasi-Monrol, Edan Diagnostics, Edan Instruments, Edico Genome, Edinburgh Innovations, Edinburgh Molecular Imaging, EDP Biotech, Edwards Lifesciences, Efferent Labs, Eigen, EIKOS Care Medical, Eisai, Eisai S.A.S, eKare, EKF Diagnostics, EKF Diagnostics (Germany), Eko, Eldan, Electrical Geodesics, Elekta, Elesta, Elevation Oncology, Eleven Biotherapeutics, Eli Lilly, Elithea Sciences, Ellerca Health, Ellume, ElMindA, Elucid Bioimaging, Elucigene, Eluthia, Embryo Ventures, EMC, EMD Millipore, eMed, Emerald Organic Growth, Emergency Medicine Foundation, Emmes, EMM Life Science, Emory Healthcare, Emory University, Empatica, Empire Genomics, Empowered Diagnostics, EMTensor, Emulate, Enable Biosciences, Ender Diagnostics, Endocanna Health, EndoChoice, EndoClot Plus, Endotronix, ENDRA Life Sciences, Enigma Biomedical, Enlitic, Entellus Medical, Enterome Bioscience, Envista, Enzo Biochem, Enzyre, Enzyvant Science, EOS Imaging, Epic, Epica Medical Innovations, EpicGenetics, Epicore Biosystems, Epic Sciences, Epigenomics, Epimune Diagnostics, Epiphany Dermatology, Epivax, Epredia, Epsilon, Erasmus University Medical Center, ERBA Diagnostics, Erisyon, ERT, Esaote, ESSA Pharma, Essenlix, Essen University Hospital, Ethos Laboratories, Ethos Research & Development, Ethos Veterinary Health, ETView Medical, Eureka Eurostars, Eurobio, Eurocine Vaccines, EuroClone, Eurofins Genomics, Eurofins LifeCodexx, Eurofins Scientific, Euroimmun, European Commission, European Health Centre Innovation, European Molecular Genetics Quality Network, European Organization for Research and Treatment of Cancer, European Prevention Center, European Prevention of Alzheimer’s dementia Initiative (EPAD), European Union, EV Biologics, Event Cardio Group, Everly Health, EverlyWell, Eversana, Everything Genetic, Evexia Diagnostics, EvoEndo, Evogen, Evotec, Exact Imaging, Exact Sciences, Exagen Diagnostics, Exalenz Bioscience, Excella, Exosome, Exosome Diagnostics, Exosome Sciences, ExoStat Medical, Expedeon, Expesicor, Exponent Private Equity, ExSeed, EyeTracking, Ez Sleep Technologies, F-Star Therapeutics, FABPulous, Fabric Genomics, Facebook, Factorial Diagnostics, Faes Farma, Falco, Fannin, Faron Pharmaceuticals, Fast-Track Diagnostics, FASTVet, Federal Ministry of Education and Research (BMBF), FedMed, FEI, Feinstein Institute for Medical Research, Ferring Pharmaceuticals, Ferrum Health, FetoLumina Technologies, Fianostics, FibriCheck, Finnish Funding Agency for Technology and Innovation (TEKES), Finnish Institute for Health and Welfare, Fio, First Check Diagnostics, First Genetics JCS, FISBA, Fisher Healthcare, FitBit, Five Prime Therapeutics, Flagship Biosciences, Flatiron Health, Fleming Fund, Flemish agency for Innovation by Science and Technology, FlexDex, Flirtey, Florida International University, FlowMetric, Fluidigm, Fluoresentric, Fluxergy, Fluxion Biosciences, FLX Bio, Flywheel, FNApath, Focal Healthcare, Fondation Cancer, Fondatioun Kriibskrank Kanner, Food and Drug Administration (FDA), Forsitech, Fortelinea Software Systems, Fortified Provider Network, Fosun Pharmaceutical, Foundation for Innovative New Diagnostics, Foundation for the National Institutes of Health (FNIH), Foundation Medicine, Fox Chase Cancer Center, Frankenman Medical Equipment, Fraunhofer Institute for Microelectronic Circuits and Systems, Fred Hutchinson Cancer Research Center, Freenome, Fresenius, Fresenius Kabi Pharmaceuticals, Fresenius Medical Care, frog, Fudan University, Fujifilm, Fujifilm medical systems, FUJIFILM SonoSite, Fujirebio Diagnostics, Fukuda Denshi, Fulcrum Therapeutics, Fulgent Genetics, Functional Gut Diagnostics, Fundacion Progreso y Salud, Fusion Antibodies, Fusion Genomics, Fuzionaire Diagnostics, Fuzionaire Radioisotope Technologies, G42 Healthcare, Galapagos, Galaxy Health Network, Galderma, Galectin Therapeutics, Galmed Pharmaceuticals, Gamidor Diagnostics, Gamma Medica, GANZIMMUN Diagnostics, Gastrologix, GBS, GCS Sesan, Gedeon Richter, GE Healthcare, Geisinger Medical Center, GEMCO Medical, Gemelli Biotech, Gemini Therapeutics, Gen-Probe, Genalyte, Genclis, Gencove, Genecast, GeneCentric Therapeutics, GeneDX, GeneInsight, GeneNews, Genentech, GenePeeks, GenePOC, GeneQuantum Healthcare, Geneseeq, GenesisCare, GeneThera, Genetic Analysis, Genetic Technologies, Genetron Health, Geneva University Hospitals, Genewell Biotechnology, Genewiz, Genfit, GENinCode, Genmab, Genoma, Genomac Research Institute, Genome Canada, GenomeDx, Genome Institute of Singapore, Genomeon, Genome Prairie, GenomeSmart, Genomic Health, Genomics England, Genomic Testing Cooperative, Genomind, Genomoncology, Genoptix, Genosity, Genotests, Genova Diagnostics, GenScript Biotech, GensKey Medical Technology, Gentag, Gentex, Genticel, Geo-Med, George Mason University, Georgetown University, George Washington University, Georgia Institute of Technology, German Cancer Research Center, German Federal Ministry of Education and Research, Gestalt Diagnostics, GE Ventures, GHR Foundation, Gibraltar Brothers and Associates, Gibson Oncology, Gilead Sciences, GIMDx, Ginkgo BioWorks, GI OnDEMAND, GI Reviewers, GlaxoSmithKline, GLG Pharma, Global Cancer Diagnostics, Global Dx, Global Good Fund, Global Lung Cancer Coalition, Global Medical Solutions, Global Virus Network, Global WholeHealth Partners, Globavir Biosciences, Glooko, Gloval Specimen Solutions, GlucoModicum, Glytec, Glythera, gMed Canada, GNA Biosolutions, Gnomegen, GNS Healthcare, GNYHA Services, Goffin Molecular Technologies, Golden Valley Development, Golden Vine International, Gold Standard Diagnostics, GoMeyra, Good Start Genetics, Goodwin Biotechnology, Google, Gotect Diagnostic, Government of Canada, Government Scientific Source, Grail, GrandOmics Biosciences, Grand River Aseptic Manufacturing, Granville Biomedical, Gravity Diagnostics, Great Basin Scientific, Greater New York Hospital Association, Great Lakes Medical Laboratory, Green Cross Medical Science, Greenfield Global, Greiner Bio-One, Group K Diagnostics, Group Vida, Growshapes, Grupo Ferrer, GSK Consumer Healthcare, GT Molecular, GTP Technology, Guangzhou Institute of Respiratory Disease, Guardant Health, Guerbet, Guided Therapeutics, Guided Therapy Systems, Gyros Protein Technologies, Hackensack Meridian Health, Hadassah Medical Center, Hai Kang Life, Hainan Sinotau Pharmaceutical, HalioDx, HALO Diagnostics, Halo Dx, Halozyme Therapeutics, Halt Medical, Hamamatsu Photonics, Hamilton Company, Hamilton Health Sciences, Hamilton Robotics, Hangzhou Tigermed Consulting, Hardy Diagnostics, Hartford HealthCare, Harvard Bioscience, Harvard Medical School, Harvard Pilgrim Health Care, Harvard University, Hawaii Medical, Healgen Scientific, Healius, HEALTH Biomed, Health Canada, HealthCare Konnect, Health Diagnostics Laboratory, Healthimation, Health Logic Interactive, HealthLytix, Healthmark Industries, HealthMyne, Health Network Laboratories, Health Recovery Solutions, Healthsense, HealthTab, HealthTrust, HealthTrust Purchasing Group, Healthvana, Heartflow, HeartGenetics, HeartHero, HeartIT, HeartScore, Heat Biologics, Hebrew University of Jerusalem, Heidelberg Pharma, Helio Health, heliosDX, Helix, Helix2, HelixBind, Helomics, HemaTone, Hememics Biotechnologies, Hemex Health, Hemogenomics Pharma, HemoShear, Henan Province People's Hospital, Hengrui Therapeutics, Henlius Biotech, Hennepin County Medical Center, Henry Ford Health System, Henry M. Jackson Foundation, Henry Schein, HepQuant, Hepregen, Hereditary Neuropathy Foundation, Heritage Valley Health System, Hermes Medical Solutions, Herzog Surgical, Heska, Hesperos, HiberCell, High Desert Heart Institute, Highmark Blue Shield, HiMedia Laboratories, HistoCyte Laboratories, HistoIndex, Hitachi, Hitachi Aloka Medical, Hitachi Chemical, Hitachi High-Technologies Corporation, Hitachi Medical Systems Europe, HMicro, HMNC Brain Health, Hoag Memorial Hospital Presbyterian, Hob Diagnostics, Holberg EEG, Hologic, Honeywell, Hoowaki, Horizon 2020, Horizon Blue Cross Blue Shield, Horizon Discovery, Horizon Therapeutics, Hospital Fondation Adolphe de Rothschild, Hospital for Special Surgery, Hospital of University of Strasbourg, Hospital Services, Hoth Therapeutics, HotSpot Therapeutics, Houston Healthcare, HOYA Corporation, HP, HR Pharmaceuticals, HTG Molecular Diagnostics, Huakang Biomedical, Huami, Huawei, Hubrecht Organoid Technology, Hudson Robotics, Huma, Humana, Human Longevity, Human Metabolome Technologies, HuminTec, Hummingbird Bioscience, Hummingbird Diagnostics, Hunan Xing Hang Rui Kang Bio-Technologies, Huntsman Cancer Institute, Huvitz, Hvidovre Hospital, hVIVO, Hybridyne Imaging Technologies, Hygea Precision Medicine, Hy Laboratories, Hyperfine Research, I-mab, I-MED Pharma, IBA, IBA Molecular Imaging, Ibex Medical Analytics, iBIO Institute’s PROPEL Center, IBL America, IBM, IBM Watson Health, iCAD, Icagen, Icahn School of Medicine at Mount Sinai, iCardiac Technologies, Ichor Blood Services, Icometrix, Icon, ICT Health, Idaho Urologic Institute, IDbyDNA, IDEAS DWC, Idengene, IDenta, IdentifySensors Biologics, IDEXX Laboratories, IDIBELL, IDx, IES Diagnostics, Ifa Systems, ii Ventures, Ikonopedia, Illumigyn, Illumina, ImaBiotech, Image Analysis, ImageIQ, ImageMover, Image Stream Medical, ImaginAb, Imaging Advantage, Imaging Associates, Imagin Medical, Imago Systems, Imalogix, Imanis Life Sciences, Imanova, Imaware, Imbio, IMD Companies, Imec, Imegen, Imeka, IMIDomics, ImmersiveTouch, ImmunArray, Immunexpress, ImmunID Technologies, ImmunoCellular Therapeutics, Immuno Diagnostic, ImmunoPrecise Antibodies, Immunovia, iMotions, IMPACT Therapeutics, ImpediMed, Imperial College London, Imperial Innovations, Imricor Medical Systems, IMRIS, Inagene Diagnostics, INanoBio, Inari Medical, InBios International, IncellDx, Incyte, InDevR, Indiana University, Indica Labs, Indigo Biosciences, Indivumed, Infectolab Americas, Infervision, Infinity BiologiX, Infinovo Medical, Inflammatix, Inflammatory Breast Cancer Research Foundation, Inflazome, InfoBionic, Inform Diagnostics, Informed Data Systems, InformedDNA, Inform Genomics, Infrared Cameras, Ingenza, inHEART, Inhibrx, Inivata, InnerOptic Technology, Innosieve Diagnostics, InnoTech Precision Medicine, Innova Biosciences, Innovate BC, Innovate UK, Innovation Skane, Innovation Zed, Innovative Diagnostic Laboratory, Innovative Manufacturing Cooperative Research Centre, Innovo, Innovus Pharmaceuticals, Inotrem, Inova Health System, Inova Labs, Inova Translational Medicine Institute, Inovio Pharmaceuticals, Inscopix, Inserm, Inserm Transfert, InSightec, Insight Genetics, InstaNatural, Institut Català d'Oncologia, Institut Curie, Institut de Radiofarmacia Aplicada de Barcelona, Institute for Bioscience and Biotechnology Research, Institute for Genome Statistics and Bioinformatics, Institute for Systems Biology, Institute of Biophysics, Institute of Cancer Research, Institute of Human Genetics, Institute of Organic Chemistry and Biochemistry, Institute of Virology and Immunology, Institut Gustave Roussy, Instituto Diagnostico Varelli, Institut Paoli-Calmettes, Institut Pasteur, Instrumentation Laboratory, Insulet, Intalere, IntegraGen, Integrated Biobank of Luxembourg, Integrated Computer Solutions, Integrated Diagnostics, Integrated DNA Technologies, Integrated Micro-Chromatography Systems, Integrity Applications, Intelerad Medical Systems, Intelligence Advanced Research Projects Activity (IARPA), Interlab INTERAUTOMATIKA UAB, Interleukin Genetics, Intermountain Healthcare, International Association for the Study of Lung Cancer, International Isotopes, International Progressive MS Alliance, Interpace Diagnostics, Interpace Diagnostics Group, Interscope, InterSystems, Intezyne, Intra Globus Biosystems, IntroMedic, Invenio Imaging, Invenra, inVentiv Health, inviCRO, Invitae, InVivoScribe, Ionian University, Ionis Pharmaceuticals, ION Solutions, Ion Torrent, IP Biotech, IPS Genomix, IQ-AI, iQ Group, IRE Elit, iRemedy Healthcare Companies, iRhythm Technology, IRIS, IRIS International, IronHealth, Iron Horse Diagnostics, Ironwood Pharmaceuticals, IRX Therapeutics, iSchemaView, Isologic Innovative Radiopharmaceuticals, IsoPlexis, ISOThrive, Isotope Technologies Garching, Isotopia Molecular Imaging, Istituto Diagnostico Varelli, Itamar Medical, ITEL, Item, ITEM Medical Technologies, Iterative Scopes, iThera Medical, ITM Isotopen Technologien, ITOCO, Itus, Ives EEG Solutions, IviGen, IXICO, Jain Foundation, James S. McDonnell Foundation, Jana Care, Jan Medical, Janssen-Cilag, Janssen Biotech, Janssen Diagnostics, Janssen Pharmaceuticals, Janssen Pharmaceutica NV, Janssen Research & Development, Japan Agency for Medical Research and Development, Jazz Pharmaceuticals, Jefferson Healthcare, Jeffrey Modell Foundation, JFE Engineering, Jiangsu Chia Tai Tianqing Pharmaceutical, Jiangsu Egens Biotechnology, Jiangsu Hengrui Medicine, Jiangsu Vedkang Medical Science and Technology, JNC Medical, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins Medicine (JHM), Johns Hopkins University, Johnson & Johnson, Johnson & Johnson Innovation, Johnson & Johnson Vision, John Wayne Cancer Institute, Joint Venture Partner Group, JTS Health Partners, Juama, Jubilant DraxImage, Jubilant Radiopharma, Juno Therapeutics, Juntendo University, K2M, Kailos Genetics, KA Imaging, Kaiser Foundation Research Institute, Kaiser Permanente, Kanazawa University, Kansas University Medical Center (KUMC), Kantaro Biosciences, Kanteron Systems, Kantonsspital Baselland, Karius, Karolinska Institute, Karolinska University Hospital, Kartos Therapeutics, Katalyst Diagnostics, KDx Diagnostics, Keck School of Medicine of USC, Keio Gijuku University, Kent Imaging, Kessler Foundation, Kettering Health, KEW, Kheiron Medical Technologies, Kim & Friends, Kindstar Globalgene Technology, KingMed Diagnostics, Kings College London, Kiromic Biopharma, Kite Pharma, Kiyatec, KK Women’s and Children’s Hospital, KMG International, Knight Cancer Institute, Know Labs, Konica Minolta, Konica Minolta Precision Medicine, Kore, Korea Pharma, KromaTiD, Krystal Biotech, KSL Biomedical, KSL Diagnostics, KUB Technologies, Kurabo, Kura Oncology, Kuwait Government, L1 Enterprises, L1 Systems, Lab21, Labcyte, Labgene Scientific, Lab Genomics, Laboratory Corporation of America, Laboratory Supply Company (LABSCO), LabPro, Labrador Technologies, LabStyle Innovations, La Jolla Institute for Allergy & Immunology, Lambell Ghana, LamdaGen, Lantern Pharma, Lantheus Holding, Lantheus Medical Imaging, Lark Technologies, Launch Diagnostics, Laurel Bridge Software, LDR Holding, Leap Therapeutics, Lee Health, Lee Moffitt Cancer Center, Legacy Of Angels Foundation, Lehigh University, Leica Biosystems, Leica Microsystems, Leicester University, Leiden University, Leinco Technologies, Leonie Hill Capital, LEO Pharma, Les Laboratoires Servier, LexaGeneFor the full list of companies email us on enquiry@currentpartnering.com

 

Current Partnering reports provide insight into the trends and terms of partnering deals in the global life sciences sector.

Current Partnering reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.

Current Partnering analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.

Current Partnering reports source deal data from our proprietary deals and alliances database, Current Agreements. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal. In addition, deal records are updated with new data as it becomes available.

The data in the Current Agreements deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.

Current Partnering provides comprehensive coverage of the following partnering or deal types:
• Asset purchase
• Assignment
• Co-development
• Co-market
• Co-promotion
• Collaborative R&D
• Contract service
• CRADA
• Cross-licensing
• Development
• Distribution
• Equity purchase
• Evaluation
• Grant
• Joint venture
• Licensing
• Loan
• Manufacturing
• Marketing
• Option
• Promotion
• Research
• Royalty financing
• Settlement
• Spin out
• Sub license
• Supply
• Termination
• Warrant

Every deal record is fully categorized and includes the following data, where available:
• Industry sector
• Therapy areas
• Technology type
• Deal components
• Financial terms
• Stage of development
• Exclusivity
• Asset type
• Geographic focus
• Excluded geography
• Company press release
• SEC filing data including contract document

All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.

Financial data and contract documents displayed in deal records is obtained from public sources, where disclosed by the parties to the deal.